CA
LMAT icon

Continuum Advisory’s LeMaitre Vascular LMAT Stock Holding History

Continuum Advisory’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8
Closed -$812 – 1923
2024
Q3 		$812 Buy
+8
New +$693 ﹤0.01% 1674

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Continuum Advisory's LMAT Position: Q4 2024 in Review

Continuum Advisory sold out of LeMaitre Vascular (LMAT) in Q4 2024, closing a stake of 8 shares — an estimated $812 sold.

Continuum Advisory first reported a position in LMAT in Q3 2024 and held it in 1 quarter. The position peaked at $812 in Q3 2024. 307 funds tracked by Wall St. Rank hold LMAT as of Q4 2024.

  • Continuum Advisory reported no remaining LeMaitre Vascular position as of Q4 2024 after selling out during the quarter.
  • Continuum Advisory sold 8 LeMaitre Vascular shares in Q4 2024, an estimated $812.
  • Continuum Advisory first reported a position in LeMaitre Vascular in Q3 2024 and held it in 1 quarter.
  • Continuum Advisory's LeMaitre Vascular position peaked at $812 in Q3 2024.
  • 307 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2024.

Based on Continuum Advisory's 13F filing for Q4 2024, filed 18 Feb 2025.